Tudor Investment Corp
CGON icon

Tudor Investment Corp’s CG Oncology CGON Stock Holding History

Tudor Investment Corp’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-37,759
Closed -$1.42M – 3056
2024
Q3 		$1.42M Buy
+37,759
New +$1.32M 0.01% 1412

Other funds holding CGON

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tudor Investment Corp's CGON Position: Q4 2024 in Review

Tudor Investment Corp sold out of CG Oncology (CGON) in Q4 2024, closing a stake of 37,759 shares — an estimated $1.42M sold.

Tudor Investment Corp first reported a position in CGON in Q3 2024 and held it in 1 quarter. The position peaked at $1.42M in Q3 2024. 140 funds tracked by Wall St. Rank hold CGON as of Q4 2024.

  • Tudor Investment Corp reported no remaining CG Oncology position as of Q4 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 37,759 CG Oncology shares in Q4 2024, an estimated $1.42M.
  • Tudor Investment Corp first reported a position in CG Oncology in Q3 2024 and held it in 1 quarter.
  • Tudor Investment Corp's CG Oncology position peaked at $1.42M in Q3 2024.
  • 140 funds tracked by Wall St. Rank held CG Oncology as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.